Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
tick-borne encephalitis vaccine (TICOVAC) (2 trials)
gemcitabine (gemzar) (1 trial)
ocz103-os (1 trial)
propionyl l-carnitine (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Encephalitis (Phase 3)
Encephalitis, Tick-Borne (Phase 3)
Lung Neoplasms (Phase 2)
Ulcer (Phase 2)
Trials (4 total)
Trial APIs (4 total)